BLA accepted, priority review granted by US FDA for Viridian Viridian Therapeutics’ veligrotug | Optometry Times - Clinical News

Published on December 22, 2025
The PDUFA target action date is June 30, 2026.
Continue reading on website
Other news

The Body Doctor co-founders to take on London Marathon

December 22, 2025
Sam and Adam Wymer will run the 2026 London Marathon to raise funds for Pancreatic Cancer UK, in memory of their father

American Optometric Association

December 23, 2025
There’s something for everyone at Optometry's Meeting: https://ow.ly/qHRy50XNIxvFrom hands-on clinical education and expansive learning opportunities to numerous events to network with peers and...